Literature DB >> 35244698

Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine.

Gajanan Sapkal1, Rajni Kant2, Gaurav Dwivedi2, Rima R Sahay1, Pragya D Yadav1, Gururaj R Deshpande1, Rajeev Singh2, Dimpal A Nyayanit1, Deepak Y Patil1, Anita M Shete-Aich1, Kamran Zaman2, Anil K Chaudhari3, Nivedita Gupta4, Samiran Panda4, Priya Abraham1, Balram Bhargava4.   

Abstract

Entities:  

Keywords:  Covaxin; Covishield; Omicron; SARS-CoV-2; heterologous vaccination; neutralization

Mesh:

Substances:

Year:  2022        PMID: 35244698      PMCID: PMC8903478          DOI: 10.1093/jtm/taac033

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  2 in total

Review 1.  Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review.

Authors:  Zhonghao Chen; Ying Zhang; Meng Wang; Md Sahidul Islam; Ping Liao; Yuanjia Hu; Xin Chen
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

2.  Inactivated vaccine Covaxin/BBV152: A systematic review.

Authors:  Tousief Irshad Ahmed; Saqib Rishi; Summaiya Irshad; Jyoti Aggarwal; Karan Happa; Sheikh Mansoor
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.